MAXIM PHARMACEUTICALS INC
8-K/A, EX-23.1, 2000-08-22
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: MAXIM PHARMACEUTICALS INC, 8-K/A, EX-2.4, 2000-08-22
Next: VERISIGN INC/CA, 8-K/A, 2000-08-22



<PAGE>

                                                                   Exhibit 23.1

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the use of our report dated March 24, 2000 with respect to the
financial statements of Cytovia, Inc. included in the Current Report on Form
8-K/A of Maxim Pharmaceuticals, Inc., filed with the Securities and Exchange
Commission.

                                                /s/ ERNST & YOUNG LLP

San Diego, California
August 18, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission